Botulinum toxin A (Allergan). AGN 191622, Botox.
D019274:Botulinum Toxins, Type A / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D009466:Neuromuscular Blocking Agents; D019274:Botulinum Toxins, Type A